BACKGROUND: Health facility stock-outs of artemether-lumefantrine (AL), the common first-line therapy for uncomplicated malaria across Africa, adversely affect effective malaria case-management. They have been previously reported on various scales in time and space, however the magnitude of the problem and trends over time are less clear. Here, 2010-2011 data are reported from public facilities in Kenya where alarming stock-outs were revealed in 2008. METHODS: Data were collected between January 2010 and June 2011 as part of 18 monthly cross-sectional surveys undertaken at nationally representative samples of public health facilities. The primary monitoring indicator was total stock-out of all four weight-specific AL packs. The secondary indicators were stock-outs of at least one AL pack and individual stock-outs for each AL pack. Monthly proportions and summary means of the proportions over the monitoring period were measured for each indicator. Stock-out trends were assessed using linear regression. RESULTS: The number of surveyed facilities across 18 time points ranged between 162 and 176 facilities. The stock-out means of the proportion of health facilities were 11.6% for total AL stock-out, 40.6% for stock-out of at least one AL pack, and between 20.5% and 27.4% for stock-outs of individual AL packs. Monthly decrease of the total AL stock-out was 0.005% (95% CI: -0.5 to +0.5; p = 0.983). Monthly decrease in the stock-out of at least one AL pack was 0.7% (95% CI: -1.5 to +0.3; p = 0.058) while stock-outs of individual AL packs decreased monthly between 0.2% for AL 24-pack and 0.7% for AL six-pack without statistical significance for any of the weight-specific packs. CONCLUSIONS: Despite lower levels of AL stock-outs compared to the reports in 2008, the stock-outs at Kenyan facilities during 2010-2011 are still substantial and of particular worry for the most detrimental:- simultaneous absence of any AL pack. Only minor decrease was observed in the stock-outs of individual AL packs. Recently launched interventions to eliminate AL stock-outs in Kenya are fully justified.
BACKGROUND: Health facility stock-outs of artemether-lumefantrine (AL), the common first-line therapy for uncomplicated malaria across Africa, adversely affect effective malaria case-management. They have been previously reported on various scales in time and space, however the magnitude of the problem and trends over time are less clear. Here, 2010-2011 data are reported from public facilities in Kenya where alarming stock-outs were revealed in 2008. METHODS: Data were collected between January 2010 and June 2011 as part of 18 monthly cross-sectional surveys undertaken at nationally representative samples of public health facilities. The primary monitoring indicator was total stock-out of all four weight-specific AL packs. The secondary indicators were stock-outs of at least one AL pack and individual stock-outs for each AL pack. Monthly proportions and summary means of the proportions over the monitoring period were measured for each indicator. Stock-out trends were assessed using linear regression. RESULTS: The number of surveyed facilities across 18 time points ranged between 162 and 176 facilities. The stock-out means of the proportion of health facilities were 11.6% for total AL stock-out, 40.6% for stock-out of at least one AL pack, and between 20.5% and 27.4% for stock-outs of individual AL packs. Monthly decrease of the total AL stock-out was 0.005% (95% CI: -0.5 to +0.5; p = 0.983). Monthly decrease in the stock-out of at least one AL pack was 0.7% (95% CI: -1.5 to +0.3; p = 0.058) while stock-outs of individual AL packs decreased monthly between 0.2% for AL 24-pack and 0.7% for AL six-pack without statistical significance for any of the weight-specific packs. CONCLUSIONS: Despite lower levels of AL stock-outs compared to the reports in 2008, the stock-outs at Kenyan facilities during 2010-2011 are still substantial and of particular worry for the most detrimental:- simultaneous absence of any AL pack. Only minor decrease was observed in the stock-outs of individual AL packs. Recently launched interventions to eliminate AL stock-outs in Kenya are fully justified.
Authors: Sibylle Gerstl; Sophie Dunkley; Ahmed Mukhtar; Samuel Baker; Jacob Maikere Journal: Trans R Soc Trop Med Hyg Date: 2010-02-02 Impact factor: 2.184
Authors: Beth B Kangwana; Julius Njogu; Beatrice Wasunna; Sarah V Kedenge; Dorothy N Memusi; Catherine A Goodman; Dejan Zurovac; Robert W Snow Journal: Am J Trop Med Hyg Date: 2009-05 Impact factor: 2.345
Authors: Netta Beer; Abdullah S Ali; Guida Rotllant; Ali K Abass; Rahila S Omari; Abdul-wahiyd H Al-mafazy; Anders Björkman; Karin Källander Journal: Trop Med Int Health Date: 2009-06-17 Impact factor: 2.622
Authors: Dejan Zurovac; James K Tibenderana; Joan Nankabirwa; James Ssekitooleko; Julius N Njogu; John B Rwakimari; Sylvia Meek; Ambrose Talisuna; Robert W Snow Journal: Malar J Date: 2008-09-19 Impact factor: 2.979
Authors: David J Bell; Dan Wootton; Mavuto Mukaka; Jacqui Montgomery; Noel Kayange; Phillips Chimpeni; Dyfrig A Hughes; Malcolm E Molyneux; Steve A Ward; Peter A Winstanley; David G Lalloo Journal: Malar J Date: 2009-08-26 Impact factor: 2.979
Authors: S V Dlamini; R J Kosgei; N Mkhonta; Z Zulu; K Makadzange; S Zhou; P Owiti; W Sikhondze; J Namboze; A Reid; S Kunene Journal: Public Health Action Date: 2018-04-25
Authors: Sophie Githinji; Samwel Kigen; Dorothy Memusi; Andrew Nyandigisi; Agneta M Mbithi; Andrew Wamari; Alex N Muturi; George Jagoe; Jim Barrington; Robert W Snow; Dejan Zurovac Journal: PLoS One Date: 2013-01-17 Impact factor: 3.240
Authors: Sarah V Kedenge; Beth P Kangwana; Evelyn W Waweru; Andrew J Nyandigisi; Jayesh Pandit; Simon J Brooker; Robert W Snow; Catherine A Goodman Journal: PLoS One Date: 2013-01-14 Impact factor: 3.240
Authors: Jessica L Cohen; Prashant Yadav; Corrina Moucheraud; Sarah Alphs; Peter S Larson; Jean Arkedis; Julius Massaga; Oliver Sabot Journal: PLoS One Date: 2013-07-29 Impact factor: 3.240